2013 Workshop Sessions

Workshops will offer a chance to review the latest treatment data and health care policies, examine their implications for our patients, and strengthen the skills needed to improve the quality of services.


Basic Track: We offer a special sequence of workshops designed to act as a refresher for seasoned professionals and to meet the needs of individuals who are new to this field. Those who attend all six sessions listed will receive a special certificate of completion.

Basic Track Workshop Sessions: A1, B1, C1, D1, E1 and F1


Monday, November 11, 2013/ 10:30 a.m. – 12:00 p.m.
A1 Meeting the Needs of Patients with Co-Occuring Disorders
A2 Impact of HIT and Health Reform on Medication Assisted Treatment
A3 Alcohol and Benzodiazepines during Agonist Opioid Treatment (AOT)
A4 The Far Reaching benefits of Patient Advisory and Advocacy Groups
A5 Hot Button Issues for Risk Management for Methadone Treatment

Monday, November 11, 2013/ 1:30 p.m. – 3:00 p.m.
#1 Implementing MAT Policy and Services in East Africa
#2 OTP Health Homes: A Collaborative Model for Development and Implementation
#3 Yoga Nidra in OTP

Monday, November 11, 2013/ 4:00 p.m. – 5:30 p.m.
B1 50 Year Follow-up of Methadone Treatment for Opioid Addiction
B2 Federal Health Policy Update for the Substance Use Disorder Field
B3 Increasing Availability of MAT for Opioid- Dependent Offenders at Re-Entry
B4 New Jersey Statewide Implementation of Medication Assisted Treatment
B5 Opioid Agonists & Cardiac Safety: Pharmacovigilance & ECG Implementation

Tuesday, November 12, 2013/ 10:30 a.m. – 12:00 p.m.
C1 Therapeutic Partnerships: The Most Important Evidence-Based Practice
C2 Implications/Opportunities of Health Homes for Opioid Treatment Providers
C3 Vietnam: Developing Capacity for MMT in a Low Resource Environment
C4 More than Abstinence: Supporting Physical Health and Well-Being in OTPs
C5 Development and Implementation of Recovery-Oriented BPG for Buprenorphine

Tuesday, November 12, 2013/ 1:30 p.m. – 3:00 p.m
DI Management of Benzodiazepines in Medication Assisted Treatment
D2 Use of Prescription Drug Monitoring Programs in Opioid Treatment Programs
D3 Engaging and Retaining Younger Veterans in Treatment
D4 Strategies to Minimize Neonatal Abstinence Syndrome (NAS)
D5 Improving Medication-Assisted Treatment (MAT)

Wednesday, November 13, 2013/ 8:00 a.m. – 9:30 a.m. 
E1 The MOTHER Study: What about the children?
E2 A Data-Driven Approach to Managing Risk and Monitoring Recovery
E3 Benzodiazepine Risk and Management in OTPs
E4 Recovery Model Using OTPs in the Criminal Justice System
E5 Overdose Prevention Education and Take-home Naloxone

Wednesday, November 11, 2013/ 9:45 a.m. – 11:15 a.m.
F1 Beyond “Beyond MARS”: A Look at Three of the MARS Expansion Projects Peer Support Programs
F2 The Joint Commission’s New Behavioral Health Home Certification Program
F3 I Can’t Sleep! Understanding & Treating Sleep Issues in Methadone Patients
F4 Young Patients Recovery Initiative: Enhancing Treatment for Youth in MAT
F5 Cannabis Use and Abuse: Physiology, Usage Trends and Risks




Share This